5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.40▼ | 1.40▼ | 1.39▼ | 1.42▼ | 1.32▲ |
MA10 | 1.39▼ | 1.40▼ | 1.39▼ | 1.39▲ | 1.29▲ |
MA20 | 1.40▼ | 1.40▼ | 1.41▼ | 1.33▲ | 1.46▼ |
MA50 | 1.41▼ | 1.43▼ | 1.41▼ | 1.33▲ | 1.88▼ |
MA100 | 1.44▼ | 1.40▼ | 1.37▲ | 1.50▼ | 2.47▼ |
MA200 | 1.40▼ | 1.32▲ | 1.30▲ | 1.82▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.001▲ | 0.001▲ | -0.002▼ | 0.010▲ | 0.029▲ |
RSI | 42.352▼ | 42.690▼ | 44.868▼ | 53.949▲ | 44.672▼ |
STOCH | 44.444 | 64.583 | 69.957 | 47.060 | 38.937 |
WILL %R | -100.000▼ | -31.250 | -47.619 | -47.619 | -47.882 |
CCI | -112.778▼ | -31.111 | -47.312 | 26.842 | 16.672 |
Tuesday, September 30, 2025 05:12 AM
BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (“AI”) and machine learning to enable the ...
|
Thursday, September 25, 2025 05:20 AM
Sales launch marks pivotal commercial milestone, unlocking up to $30 million in potential revenue through 2028GAITHERSBURG, Md., Sept. 25, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: ...
|
Thursday, September 25, 2025 05:10 AM
BullFrog AI (BFRG) announced that its collaboration with Sygnature Discovery specializing in drug discovery, has entered the commercial phase.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
30/09/25 | 1.40 | 1.42 | 1.37 | 1.40 | 65,405 |
29/09/25 | 1.41 | 1.47 | 1.32 | 1.38 | 76,324 |
26/09/25 | 1.41 | 1.4583 | 1.41 | 1.415 | 75,927 |
25/09/25 | 1.45 | 1.4696 | 1.40 | 1.43 | 114,804 |
24/09/25 | 1.45 | 1.49 | 1.41 | 1.45 | 136,987 |
23/09/25 | 1.53 | 1.55 | 1.37 | 1.37 | 299,262 |
22/09/25 | 1.31 | 1.53 | 1.30 | 1.48 | 291,685 |
19/09/25 | 1.35 | 1.39 | 1.32 | 1.32 | 102,859 |
18/09/25 | 1.30 | 1.38 | 1.30 | 1.35 | 110,778 |
17/09/25 | 1.30 | 1.36 | 1.29 | 1.30 | 89,875 |
|
|
||||
|
|
||||
|
|